Samyang Biopharm Corporation (KRX:0120G0)
South Korea · Delayed Price · Currency is KRW 48,350
-3,250 (-6.30%)
Last updated: Jun 10, 2026, 2:00 PM KST
Samyang Biopharm Market Cap
Samyang Biopharm has a market cap or net worth of 383.69 billion as of June 10, 2026.
Market Cap
383.69B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
48,350.00
Market Cap Chart
Since November 24, 2025, Samyang Biopharm's market cap has increased from 224.56B to 383.69B, an increase of 70.86%. That is a compound annual growth rate of 169.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 383.69B | -1.71% |
| Dec 30, 2025 | 390.38B | 73.84% |
| Nov 24, 2025 | 224.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| G2GBIO | 799.97B |
| ImmuneOncia Therapeutics | 360.53B |
| HEM Pharma | 308.58B |
| NOVAREX | 239.97B |
| CellBion | 225.84B |
| Vivozon Pharmaceutical | 191.62B |
| DAE HWA Pharmaceutical | 184.80B |
| High Tech Pharm | 146.95B |